![cms region x cms region x](https://thesis.fangmeier.tech/figures/lhc_and_cms/hcal.png)
Cms region x license#
LICENSE FOR USE OF "PHYSICIANS' CURRENT PROCEDURAL TERMINOLOGY", (CPT)ĬPT codes, descriptions and other data only are copyright 2002-2020 American Medical Association (AMA).
![cms region x cms region x](https://data.formsbank.com/pdf_docs_html/301/3017/301743/page_1_thumb_big.png)
AS USED HEREIN, "YOU" AND "YOUR" REFER TO YOU AND ANY ORGANIZATION ON BEHALF OF WHICH YOU ARE ACTING. IF YOU ARE ACTING ON BEHALF OF AN ORGANIZATION, YOU REPRESENT THAT YOU ARE AUTHORIZED TO ACT ON BEHALF OF SUCH ORGANIZATION AND THAT YOUR ACCEPTANCE OF THE TERMS OF THESE AGREEMENTS CREATES A LEGALLY ENFORCEABLE OBLIGATION OF THE ORGANIZATION. IF YOU DO NOT AGREE WITH ALL TERMS AND CONDITIONS SET FORTH HEREIN, CLICK ABOVE ON THE LINK LABELED "I Do Not Accept" AND EXIT FROM THIS COMPUTER SCREEN. BY CLICKING ABOVE ON THE LINK LABELED "I Accept", YOU HEREBY ACKNOWLEDGE THAT YOU HAVE READ, UNDERSTOOD AND AGREED TO ALL TERMS AND CONDITIONS SET FORTH IN THESE AGREEMENTS. THE LICENSES GRANTED HEREIN ARE EXPRESSLY CONDITIONED UPON YOUR ACCEPTANCE OF ALL TERMS AND CONDITIONS CONTAINED IN THESE AGREEMENTS. If you choose not to accept the agreement, you will return to the Noridian Medicare home page. This includes items such as CPT codes, CDT codes, ICD-10 and other UB-04 codes.īefore you can enter the Noridian Medicare site, please read and accept an agreement to abide by the copyright rules regarding the information you find within this site. We appreciate stakeholder support and engagement with the Innovation Center and the ongoing Oncology Care Model (OCM), and seek to continue to engage stakeholders as we develop a potential Oncology Care First Model.Some of the Provider information contained on the Noridian Medicare web site is copyrighted by the American Medical Association, the American Dental Association, and/or the American Hospital Association. We welcome suggestions about the model concept that would better incentivize participation in the potential model. We also invite feedback from potential payer partners, including commercial payers and state Medicaid agencies. We are particularly interested in hearing from PGPs and HOPDs about the conceptualized participation eligibility parameters (e.g., the grouping concept), and whether they think that meeting those parameters would be feasible. We invite feedback on the interest of physician group practices (PGPs) and hospital outpatient departments (HOPDs) in participating in a potential OCF Model.
![cms region x cms region x](https://avalere.com/wp-content/uploads/2019/06/Study-Population-Characteristics-t2-768x846.png)
We welcome feedback on the potential payment methodology, including the structure and design of the monthly population payment and the performance-based payment.How could the potential model support participants’ care transformation through practice redesign activities? Specifically, how could the potential model build on lessons learned from the implementation of the practice redesign activities included in the Oncology Care Model (OCM)? What revisions or additions should be made to the OCM practice redesign activities in the potential model? The potential OCF Model would seek to improve health outcomes and quality of care for Medicare beneficiaries with cancer.In submitted written feedback, we hope to gather stakeholder input on the following targeted topics: Written feedback can be sent to until the close of the feedback period on Friday, December 13, 2019. Please note that we have extended the feedback period from Monday, Novemas we wish to give the public more time to respond. We will accept written feedback on the informal RFI, until Friday, December 13, 2019. The Centers for Medicare & Medicaid Services (CMS) Center for Medicare and Medicaid Innovation (Innovation Center) previously announced a Public Listening Session and informal Request for Information (RFI), to gather feedback on a potential Oncology Care First (OCF) Model.